Literature DB >> 25948815

Species-specific differences in the expression and regulation of α4β7 integrin in various nonhuman primates.

Siddappa N Byrareddy1, Neil Sidell2, James Arthos3, Claudia Cicala3, Chunxia Zhao4, Dawn M Little1, Paul Dunbar1, Gui X Yang2, Keely Pierzchalski5, Maureen A Kane5, Ann E Mayne1, Byeongwoon Song6, Marcelo A Soares7, Francois Villinger8, Anthony S Fauci3, Aftab A Ansari9.   

Abstract

Among nonhuman primates, SIV-infected Asian pigtailed macaques (PM) are relatively more susceptible to infection and disease progression than SIV-infected rhesus macaques (RM). In addition, SIV-infected African natural hosts such as the sooty mangabeys (SM) are resistant to disease. The mechanisms associated with such species-related variable clinical outcomes remain ill-defined but hold the potential to provide insights into the underlying mechanisms surrounding HIV pathogenesis. Recent findings indicate that the expression of the heterodimeric gut homing integrin α4β7 can influence both susceptibility and disease progression in RM. It was reasoned that differences in the frequencies/surface densities of α4β7-expressing lymphocytes might contribute to the differences in the clinical outcome of SIV infection among NHPs. In this article, we report that CD4(+) T cells from PM constitutively express significantly higher levels of α4β7 than RM or SM. Retinoic acid, a key regulator of α4β7 expression, was paradoxically found at higher levels in the plasma of SM versus RM or PM. We also observed pairing of β7 with αE (αEβ7) on CD4(+) T cells in the peripheral blood of SM, but not PM or RM. Finally, the differential mean density of expression of α4β7 in RM versus SM versus PM was predominantly dictated by species-specific sequence differences at the level of the β7 promoters, as determined by in vitro reporter/promoter construct transfection studies. We propose that differences in the regulation and expression of α4β7 may explain, in part, the differences in susceptibility and SIV disease progression in these NHP models.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25948815      PMCID: PMC4722869          DOI: 10.4049/jimmunol.1402866

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

1.  HPLC/UV quantitation of retinal, retinol, and retinyl esters in serum and tissues.

Authors:  Maureen A Kane; Alexandra E Folias; Joseph L Napoli
Journal:  Anal Biochem       Date:  2008-03-25       Impact factor: 3.365

2.  Prevention of acute graft-versus-host disease in a xenogeneic SCID mouse model by the humanized anti-CD74 antagonistic antibody milatuzumab.

Authors:  Xiaochuan Chen; Chien-Hsing Chang; Rhona Stein; Thomas M Cardillo; David V Gold; David M Goldenberg
Journal:  Biol Blood Marrow Transplant       Date:  2012-09-28       Impact factor: 5.742

3.  The frequency of α₄β₇(high) memory CD4⁺ T cells correlates with susceptibility to rectal simian immunodeficiency virus infection.

Authors:  Elena Martinelli; Filippo Veglia; Diana Goode; Natalia Guerra-Perez; Meropi Aravantinou; James Arthos; Michael Piatak; Jeffrey D Lifson; James Blanchard; Agegnehu Gettie; Melissa Robbiani
Journal:  J Acquir Immune Defic Syndr       Date:  2013-12-01       Impact factor: 3.731

4.  Quantification of endogenous retinoids.

Authors:  Maureen A Kane; Joseph L Napoli
Journal:  Methods Mol Biol       Date:  2010

Review 5.  Integrin structure, activation, and interactions.

Authors:  Iain D Campbell; Martin J Humphries
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

Review 6.  Vedolizumab for the treatment of IBD: a selective therapeutic approach targeting pathogenic a4b7 cells.

Authors:  Manol Jovani; Silvio Danese
Journal:  Curr Drug Targets       Date:  2013-11       Impact factor: 3.465

7.  Complementary roles of retinoic acid and TGF-β1 in coordinated expression of mucosal integrins by T cells.

Authors:  S G Kang; J Park; J Y Cho; B Ulrich; C H Kim
Journal:  Mucosal Immunol       Date:  2010-07-21       Impact factor: 7.313

8.  The gut microbiota and mucosal T cells.

Authors:  Patrick M Smith; Wendy S Garrett
Journal:  Front Microbiol       Date:  2011-05-26       Impact factor: 5.640

9.  TGF-{beta}-dependent CD103 expression by CD8(+) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease.

Authors:  Riham El-Asady; Rongwen Yuan; Kechang Liu; Donghua Wang; Ronald E Gress; Philip J Lucas; Cinthia B Drachenberg; Gregg A Hadley
Journal:  J Exp Med       Date:  2005-05-16       Impact factor: 14.307

10.  CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract.

Authors:  Jason M Brenchley; Timothy W Schacker; Laura E Ruff; David A Price; Jodie H Taylor; Gregory J Beilman; Phuong L Nguyen; Alexander Khoruts; Matthew Larson; Ashley T Haase; Daniel C Douek
Journal:  J Exp Med       Date:  2004-09-13       Impact factor: 14.307

View more
  8 in total

1.  The Role of Integrin Expressing Cells in Modulating Disease Susceptibility and Progression (January 2016).

Authors:  Aftab A Ansari; Siddappa N Byrareddy
Journal:  Int Trends Immun       Date:  2016-01

2.  Extracellular Matrix Proteins Mediate HIV-1 gp120 Interactions with α4β7.

Authors:  David Plotnik; Wenjin Guo; Brad Cleveland; Priska von Haller; Jimmy K Eng; Miklos Guttman; Kelly K Lee; James Arthos; Shiu-Lok Hu
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

3.  Glycosylation and oligomeric state of envelope protein might influence HIV-1 virion capture by α4β7 integrin.

Authors:  Subhash Chand; Emily L Messina; Wadad AlSalmi; Neeti Ananthaswamy; Guofen Gao; Gherman Uritskiy; Victor Padilla-Sanchez; Marthandan Mahalingam; Kristina K Peachman; Merlin L Robb; Mangala Rao; Venigalla B Rao
Journal:  Virology       Date:  2017-05-31       Impact factor: 3.616

Review 4.  Review of Integrin-Targeting Biomaterials in Tissue Engineering.

Authors:  Prachi Dhavalikar; Andrew Robinson; Ziyang Lan; Dana Jenkins; Malgorzata Chwatko; Karim Salhadar; Anupriya Jose; Ronit Kar; Erik Shoga; Aparajith Kannapiran; Elizabeth Cosgriff-Hernandez
Journal:  Adv Healthc Mater       Date:  2020-09-16       Impact factor: 9.933

5.  Coexpression Network Analysis of Benign and Malignant Phenotypes of SIV-Infected Sooty Mangabey and Rhesus Macaque.

Authors:  Zhao-Wan Yang; Yan-Hua Jiang; Chuang Ma; Guido Silvestri; Steven E Bosinger; Bai-Lian Li; Ambrose Jong; Yan-Hong Zhou; Sheng-He Huang
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240

6.  Early treatment of SIV+ macaques with an α4β7 mAb alters virus distribution and preserves CD4+ T cells in later stages of infection.

Authors:  P J Santangelo; C Cicala; S N Byrareddy; K T Ortiz; D Little; K E Lindsay; S Gumber; J J Hong; K Jelicic; K A Rogers; C Zurla; F Villinger; A A Ansari; A S Fauci; J Arthos
Journal:  Mucosal Immunol       Date:  2017-12-20       Impact factor: 7.313

Review 7.  Understanding the Role of Mucosal-Associated Invariant T-Cells in Non-human Primate Models of HIV Infection.

Authors:  Isaac M Barber-Axthelm; Stephen J Kent; Jennifer A Juno
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561

8.  Retinoic Acid Improves the Recovery of Replication-Competent Virus from Latent SIV Infected Cells.

Authors:  Omalla A Olwenyi; Arpan Acharya; Nanda Kishore Routhu; Keely Pierzchalski; Jace W Jones; Maureen A Kane; Neil Sidell; Mahesh Mohan; Siddappa N Byrareddy
Journal:  Cells       Date:  2020-09-11       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.